Jon Congleton
Algemeen Directeur bij MINERALYS THERAPEUTICS, INC.
Vermogen: 16 M $ op 30-04-2024
Actieve functies van Jon Congleton
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | 01-11-2020 | - | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Private Equity Investor | - | - |
Loopbaan van Jon Congleton
Eerdere bekende functies van Jon Congleton
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IPI LEGACY LIQUIDATION CO | Directeur/Bestuurslid | - | 05-05-2020 |
| Algemeen Directeur | 03-10-2017 | 05-05-2020 | |
| President | 03-10-2017 | 05-05-2020 | |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | Directeur/Bestuurslid | 22-12-2014 | 15-01-2017 |
| Algemeen Directeur | 22-12-2014 | 15-01-2017 | |
| President | 22-12-2014 | 15-01-2017 | |
| ALPINE IMMUNE SCIENCES, INC. | Algemeen Directeur | - | 01-01-2017 |
| President | - | 01-01-2017 | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Verkoop & Marketing | - | - |
Teva Neuroscience, Inc.
 Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Teva Neuroscience, Inc. developed and marketed drugs for neurological disorders. The company's product COPAXONE was used to reduce relapses caused by relapsing-remitting multiple sclerosis. It also offered treatment for Parkinson's disease. Teva Neuroscience was founded in 1997 and was located in Kansas City, MO | Corporate Officer/Principal | 19-11-2010 | - |
Opleiding van Jon Congleton
| Kansas State University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Israël | 2 |
| Japan | 2 |
Operationeel
| Chief Executive Officer | 4 |
| Director/Board Member | 3 |
| President | 3 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| IPI LEGACY LIQUIDATION CO | Health Technology |
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Teva Neuroscience, Inc.
Teva Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Teva Neuroscience, Inc. developed and marketed drugs for neurological disorders. The company's product COPAXONE was used to reduce relapses caused by relapsing-remitting multiple sclerosis. It also offered treatment for Parkinson's disease. Teva Neuroscience was founded in 1997 and was located in Kansas City, MO | Health Technology |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | Health Technology |
Catalys Pacific LLC
Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Finance |
- Beurs
- Insiders
- Jon Congleton
- Ervaring
